According to Travere Therapeutics's latest financial reports the company's current earnings (TTM) are -โน32.14 B. In 2023 the company made an earning of -โน30.19 B a decrease over its 2022 earnings that were of -โน24.55 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.